BUY Jindal Saw Ltd — IDBI Capital
byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))4 Nov 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
MACD below its signal line — bearish momentum
Technicals · macd·7 Nov · today
Q2 Results Underperformer: Stock falls 18% in three sessions after profit drops nearly 70%
NewsCnbc-Tv18·22 Oct · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Jindal Saw
- BUY — Amit Seth15 Oct 2026 · ~2 weeks · target ₹320 · SL hit
- BUY — Kunal Saraogi15 Oct 2026 · Same day · target ₹315 · Expired
- BUY — MarketSmith India15 Oct 2026 · ~2 weeks · target ₹342 · SL hit
- BUY — Vishvesh Chauhan, ChaseAlpha14 Oct 2026 · ~2 weeks · target ₹320 · SL hit
- BUY — Pradeep Haldar, PHD Capital10 Sept 2026 · ~3 months · target ₹337 · SL hit
More from IDBI Capital
- BUY Alkem Laboratories6 Nov 2026 · ~2 weeks · target ₹5,460 · Active
- BUY Onesource Specialty Pharma6 Nov 2026 · ~2 weeks · target ₹1,735 · Active
- BUY Sun Pharmaceutical Industries6 Nov 2026 · ~2 weeks · target ₹1,925 · Active
- BUY Vijaya Diagnostic Centre6 Nov 2026 · ~2 weeks · target ₹1,575 · Active
- BUY Rolex Rings6 Nov 2026 · ~1 year · target ₹241 · Active

